These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 39054625)

  • 1. Differences in the Prognostic Impact between Single-zone and Multi-zone N2 Node Metastasis in Patients with Station-based Multiple N2 Non-Small Cell Lung Cancer.
    Kim SA; Lee GD; Choi SH; Kim HR; Kim YH; Kim DK; Park SI; Yun JK
    Cancer Res Treat; 2024 Jul; ():. PubMed ID: 39054625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer.
    Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
    Eur J Cardiothorac Surg; 2019 Nov; 56(5):849-857. PubMed ID: 31168596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative radiotherapy option based on mediastinal lymph node reclassification for patients with pN2 non-small-cell lung cancer.
    Jin J; Xu Y; Hu X; Chen M; Fang M; Hang Q; Chen M
    Curr Oncol; 2020 Jun; 27(3):e283-e293. PubMed ID: 32669935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Review for N2 Sub-staging in Non-small Cell Lung Cancer].
    Bao Y; Hui Z
    Zhongguo Fei Ai Za Zhi; 2022 Dec; 25(12):870-876. PubMed ID: 36617473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The addition of radiotherapy to adjuvant chemotherapy has a combinatorial effect in pN2 non-small cell lung cancer only with extranodal invasion or multiple N2 metastasis.
    Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Park SI; Kim DK
    Lung Cancer; 2021 May; 155():94-102. PubMed ID: 33765654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommended Change in the N Descriptor Proposed by the International Association for the Study of Lung Cancer: A Validation Study.
    Park BJ; Kim TH; Shin S; Kim HK; Choi YS; Kim J; Zo JI; Shim YM; Cho JH
    J Thorac Oncol; 2019 Nov; 14(11):1962-1969. PubMed ID: 31442497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer.
    Asamura H; Chansky K; Crowley J; Goldstraw P; Rusch VW; Vansteenkiste JF; Watanabe H; Wu YL; Zielinski M; Ball D; Rami-Porta R;
    J Thorac Oncol; 2015 Dec; 10(12):1675-84. PubMed ID: 26709477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of International Association for the Study Of Lung Cancer proposals for the revision of N descriptors in lung cancer.
    Lee JG; Lee CY; Bae MK; Park IK; Kim DJ; Kim KD; Chung KY
    J Thorac Oncol; 2008 Dec; 3(12):1421-6. PubMed ID: 19057267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk prediction of multiple-station N2 metastasis in patients with upfront surgery for clinical single-station N2 non-small cell lung cancer.
    Kim JY; Lee HP; Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
    Sci Rep; 2024 Aug; 14(1):18800. PubMed ID: 39138302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of uncertain resection in scenarios of metastasis of the highest or most distant mediastinal lymph node station following surgical treatment of non-small-cell lung cancer.
    Park SY; Byun GE; Lee CY; Lee JG; Kim DJ; Paik HC; Chung KY
    Lung Cancer; 2019 Dec; 138():1-5. PubMed ID: 31593893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Validation Study of the Recommended Change in Residual Tumor Descriptors Proposed by the International Association for the Study of Lung Cancer for Patients With pN2 NSCLC.
    Yun JK; Lee GD; Choi S; Kim YH; Kim DK; Park SI; Kim HR
    J Thorac Oncol; 2021 May; 16(5):817-826. PubMed ID: 33607310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N2 lung cancer is not all the same: an analysis of different prognostic groups.
    Bertoglio P; Ricciardi S; Alì G; Aprile V; Korasidis S; Palmiero G; Fontanini G; Mussi A; Lucchi M
    Interact Cardiovasc Thorac Surg; 2018 Nov; 27(5):720-726. PubMed ID: 29788107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does anatomical location-based metastatic lymph node density affect prognosis in lung cancer patients?
    Aksoy Y; Çıtak N; Obuz Ç; Metin M; Sayar A
    Interact Cardiovasc Thorac Surg; 2021 Oct; 33(4):541-549. PubMed ID: 34000035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer.
    Rusch VW; Crowley J; Giroux DJ; Goldstraw P; Im JG; Tsuboi M; Tsuchiya R; Vansteenkiste J; ; ; ;
    J Thorac Oncol; 2007 Jul; 2(7):603-12. PubMed ID: 17607115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of lymph node status in completely resected IIIa/N2 small cell lung cancer: importance of subcarinal station metastases.
    Qiao R; Zhong R; Xu J; Zhang Y; Zhang B; Wang S; Lou Y; Chen D; Chang Q; Zhao Y; Han B
    J Cardiothorac Surg; 2019 Mar; 14(1):63. PubMed ID: 30925891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of nodal classification for non-small cell lung cancer by merging current N categories with the number of involved lymph node stations.
    Chen W; Zhang C; Wang G; Yu Z; Liu H
    Thorac Cancer; 2019 Jul; 10(7):1533-1543. PubMed ID: 31207184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
    Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
    Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of skip N2 lymph node metastasis for patients with the stage III-N2 lung adenocarcinoma: a propensity score matching analysis.
    Wang S; Xie S; Han Y; Gao M; Su X; Liu Q
    BMC Pulm Med; 2023 Apr; 23(1):147. PubMed ID: 37118722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boundary between N1 and N2 Lymph Node Descriptors in the Subcarinal Zone in Lower Lobe Lung Cancer: A Brief Report.
    Isaka M; Kondo H; Maniwa T; Takahashi S; Ohde Y
    J Thorac Oncol; 2016 Jul; 11(7):1176-80. PubMed ID: 27058910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Pathologic Single-Nodal and Multiple-Nodal Descriptors in Resected Non-Small Cell Lung Cancer.
    Takamori S; Osoegawa A; Hashinokuchi A; Karashima T; Takumi Y; Abe M; Yamaguchi M; Takenaka T; Yoshizumi T; Zhu J; Komiya T
    Chest; 2024 Jul; ():. PubMed ID: 39004218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.